Paralytic poliomyelitis: seasoned strategies, disappearing disease
暂无分享,去创建一个
H. Hull | J. Milstien | N. Ward | H. F. Hull | N. A. Ward | B. P. Hull | J. B. Milstien | C. de Quadros | C. D. Quadros | B. Hull
[1] J. Risi. The Control of Poliomyelitis in Brazil , 1984 .
[2] K. Chopra,et al. Antibody response of infants in tropics to five doses of oral polio vaccine. , 1989, Journal of tropical pediatrics.
[3] S. Sattar. Virus Survival in Receiving Waters , 1981 .
[4] J. Cuthie,et al. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. , 1988, American journal of epidemiology.
[5] M. Pallansch,et al. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children , 1991, The Lancet.
[6] J. Gear. Nonpolio causes of polio-like paralytic syndromes. , 1984, Reviews of infectious diseases.
[7] J. Fox. Modes of action of poliovirus vaccines and relation to resulting immunity. , 1984, Reviews of infectious diseases.
[8] J. Andrus,et al. Eradication of poliomyelitis: progress in the Americas. , 1991, The Pediatric infectious disease journal.
[9] T. John. Antibody response of infants in tropics to five doses of oral polio vaccine. , 1976, British medical journal.
[10] C. D. de Quadros,et al. Poliomyelitis case confirmation: characteristics for use by national eradication programmes. , 1992, Bulletin of the World Health Organization.
[11] M. Pallansch,et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] W. Orenstein,et al. RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZIL , 1988, The Lancet.
[13] Melnick Jl. Poliomyelitis: eradication in sight. , 1992 .
[14] M. Deming,et al. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine. , 1992, American journal of epidemiology.
[15] J. Modlin. Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization , 1991, The Pediatric infectious disease journal.
[16] J. Melnick. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. , 1984, Reviews of infectious diseases.
[17] T. Tulchinsky,et al. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. , 1989, American journal of public health.
[18] J. Castillo. Pathogens of Siphonaptera (fleas). , 1980, Bulletin of the World Health Organization.
[19] I. Onorato,et al. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. , 1991, The Journal of infectious diseases.
[20] A R Hinman,et al. Field evaluation of vaccine efficacy. , 1985, Bulletin of the World Health Organization.
[21] W. Foege,et al. Progress in polio eradication , 1993, The Lancet.
[22] R. R. Cruz. Cuba: Mass Polio Vaccination Program, 1962–1982 , 1984 .
[23] S. Plotkin. Current issues in evaluating the efficacy of oral poliovirus vaccine and inactivated poliovirus vaccine immunization , 1991, The Pediatric infectious disease journal.
[24] A. Sabin,et al. Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. , 1960 .
[25] P. Wright,et al. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. , 1991, Reviews of infectious diseases.
[26] H. Hull,et al. Screening of cases of acute flaccid paralysis for poliomyelitis eradication: ways to improve specificity. , 1992, Bulletin of the World Health Organization.